OR52W1
gene geneOn this page
Summary
OR52W1 (olfactory receptor family 52 subfamily W member 1, HGNC:15239) is a protein-coding gene on chromosome 11p15.4, encoding Olfactory receptor 52W1 (Q6IF63). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 120787 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 54 total
- MANE Select transcript:
NM_001005178
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15239 |
| Approved symbol | OR52W1 |
| Name | olfactory receptor family 52 subfamily W member 1 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000175485 |
| Ensembl biotype | protein_coding |
| Entrez | 120787 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000311352
RefSeq mRNA: 1 — MANE Select: NM_001005178
NM_001005178
CCDS: CCDS31407
Canonical transcript exons
ENST00000311352 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004472050 | 6199224 | 6200186 |
Expression profiles
Bgee: expression breadth tissue_specific, 4 present calls, max score 47.52.
Top tissues by expression
106 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bone marrow cell | CL:0002092 | 47.52 | gold quality |
| colonic epithelium | UBERON:0000397 | 42.39 | gold quality |
| sural nerve | UBERON:0015488 | 41.54 | gold quality |
| granulocyte | CL:0000094 | 40.01 | gold quality |
| tonsil | UBERON:0002372 | 38.46 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 37.96 | gold quality |
| calcaneal tendon | UBERON:0003701 | 37.41 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| right coronary artery | UBERON:0001625 | 35.40 | gold quality |
| prefrontal cortex | UBERON:0000451 | 35.34 | silver quality |
| monocyte | CL:0000576 | 35.18 | gold quality |
| leukocyte | CL:0000738 | 35.17 | gold quality |
| muscle tissue | UBERON:0002385 | 34.43 | gold quality |
| duodenum | UBERON:0002114 | 33.28 | silver quality |
| cerebellar cortex | UBERON:0002129 | 32.63 | gold quality |
| right uterine tube | UBERON:0001302 | 32.42 | gold quality |
| urinary bladder | UBERON:0001255 | 32.36 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 32.33 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 32.07 | gold quality |
| transverse colon | UBERON:0001157 | 31.31 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 30.66 | silver quality |
| lymph node | UBERON:0000029 | 30.46 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 30.14 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| rectum | UBERON:0001052 | 29.80 | silver quality |
| placenta | UBERON:0001987 | 29.79 | silver quality |
| vermiform appendix | UBERON:0001154 | 29.71 | silver quality |
| nucleus accumbens | UBERON:0001882 | 29.54 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.64 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or52w1 | ENSMUSG00000073906 |
| rattus_norvegicus | Or52w1 | ENSRNOG00000049480 |
Paralogs (51): OR51E2 (ENSG00000167332), OR51B5 (ENSG00000167355), OR51I1 (ENSG00000167359), OR51Q1 (ENSG00000167360), OR52A5 (ENSG00000171944), OR51B6 (ENSG00000176239), OR51V1 (ENSG00000176742), OR52E2 (ENSG00000176787), OR51L1 (ENSG00000176798), OR51G2 (ENSG00000176893), OR51A7 (ENSG00000176895), OR51T1 (ENSG00000176900), OR51S1 (ENSG00000176922), OR51F2 (ENSG00000176925), OR51E1 (ENSG00000180785), OR56B4 (ENSG00000180919), OR52E4 (ENSG00000180974), OR52N2 (ENSG00000180988), OR52N1 (ENSG00000181001), OR52N5 (ENSG00000181009), OR56B2 (ENSG00000181017), OR56B1 (ENSG00000181023), OR52N4 (ENSG00000181074), OR52P1 (ENSG00000181109), OR52D1 (ENSG00000181609), OR52H1 (ENSG00000181616), OR52K2 (ENSG00000181963), OR52A1 (ENSG00000182070), OR51B4 (ENSG00000183251), OR52E8 (ENSG00000183269), OR52L1 (ENSG00000183313), OR51M1 (ENSG00000184698), OR52B6 (ENSG00000187747), OR51I2 (ENSG00000187918), OR52K1 (ENSG00000196778), OR51D1 (ENSG00000197428), OR51C1 (ENSG00000197674), OR52M1 (ENSG00000197790), OR52E6 (ENSG00000205409), OR52J3 (ENSG00000205495)
Protein
Protein identifiers
Olfactory receptor 52W1 — Q6IF63 (reviewed: Q6IF63)
Alternative names: Olfactory receptor OR11-71
All UniProt accessions (1): Q6IF63
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001005178* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050402 | OR51/52/56-like | Family |
Pfam: PF13853
UniProt features (20 total): topological domain 8, transmembrane region 7, sequence variant 3, chain 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6IF63-F1 | 87.49 | 0.57 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 8
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 17 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, ID1_TARGET_GENES, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, GOBP_DETECTION_OF_CHEMICAL_STIMULUS, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY
GO Biological Process (5): signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), nervous system process (GO:0050877), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| system process | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
242 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR52W1 | SAP130 | Q9H0E3 | 606 |
| OR52W1 | CNGA4 | Q8IV77 | 601 |
| OR52W1 | CATSPER3 | Q86XQ3 | 573 |
| OR52W1 | MSANTD1 | Q6ZTZ1 | 571 |
| OR52W1 | SNUPN | O95149 | 528 |
| OR52W1 | GPR87 | Q9BY21 | 498 |
| OR52W1 | ZNF772 | Q68DY9 | 488 |
| OR52W1 | UGGT1 | Q9NYU2 | 472 |
| OR52W1 | DMP1 | Q13316 | 445 |
| OR52W1 | RDM1 | Q8NG50 | 432 |
| OR52W1 | FASTKD3 | Q14CZ7 | 427 |
| OR52W1 | STK31 | Q9BXU1 | 426 |
| OR52W1 | GPR171 | O14626 | 420 |
| OR52W1 | CCDC57 | Q2TAC2 | 419 |
| OR52W1 | DNAJC12 | Q9UKB3 | 418 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR52W1 | PROZ | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (3): PROZ (Affinity Capture-MS), PROZ (Affinity Capture-MS), OR52W1 (Negative Genetic)
ESM2 similar proteins: A0A3B3IT45, A6NGY5, A6NMU1, B3DH96, O88628, P0C646, P0C7T3, Q5J3E5, Q5J3G9, Q5J3M9, Q5QD29, Q6IF63, Q6W049, Q8NGB9, Q8NGD3, Q8NGF0, Q8NGF1, Q8NGH6, Q8NGH7, Q8NGI0, Q8NGI1, Q8NGI2, Q8NGI3, Q8NGJ4, Q8NGJ8, Q8NGJ9, Q8NGK5, Q8NGK6, Q8NGV6, Q8NH53, Q8NH55, Q8NH56, Q8NH60, Q8NH61, Q8NH63, Q8NH67, Q8NH76, Q8NHC6, Q8TCB6, Q8VBV9
Diamond homologs: A0A3B3IT45, A4D2G3, A6NF89, A6NGY5, A6NL08, A6NL26, A6NMU1, A6NND4, O88628, P0C629, P0C646, P0C7N1, P0C7T3, P23266, P23273, P23274, P30954, Q13606, Q60888, Q62007, Q6IF63, Q6IFG1, Q6W049, Q8NGA6, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGG8, Q8NGH5, Q8NGH6, Q8NGH7, Q8NGH8, Q8NGH9, Q8NGI0, Q8NGI1, Q8NGI2, Q8NGI3, Q8NGI7, Q8NGJ2, Q8NGJ3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
54 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 49 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
198 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:6199994:C:G | acceptor_gain | 0.7700 |
| 11:6199984:T:TA | acceptor_gain | 0.7300 |
| 11:6200023:A:AG | acceptor_gain | 0.7100 |
| 11:6200080:A:AG | acceptor_gain | 0.6500 |
| 11:6199995:A:AG | acceptor_gain | 0.6400 |
| 11:6200030:T:TA | acceptor_gain | 0.6300 |
| 11:6200000:T:A | acceptor_gain | 0.6200 |
| 11:6199997:ACCT:A | acceptor_gain | 0.6100 |
| 11:6199300:G:GT | donor_gain | 0.6000 |
| 11:6199947:GCCT:G | donor_gain | 0.6000 |
| 11:6199993:A:AG | acceptor_gain | 0.6000 |
| 11:6200020:C:G | acceptor_gain | 0.6000 |
| 11:6200080:ACTT:A | acceptor_gain | 0.6000 |
| 11:6200086:T:A | acceptor_gain | 0.6000 |
| 11:6199985:G:A | acceptor_gain | 0.5900 |
| 11:6200081:C:G | acceptor_gain | 0.5900 |
| 11:6199996:T:G | acceptor_gain | 0.5800 |
| 11:6200021:A:AG | acceptor_gain | 0.5800 |
| 11:6200023:ACC:A | acceptor_gain | 0.5800 |
| 11:6200024:C:G | acceptor_gain | 0.5700 |
| 11:6200014:A:AG | acceptor_gain | 0.5500 |
| 11:6200019:A:AG | acceptor_gain | 0.5500 |
| 11:6199998:C:G | acceptor_gain | 0.5300 |
| 11:6199961:T:TA | donor_gain | 0.5200 |
| 11:6199962:A:AA | donor_gain | 0.5200 |
| 11:6200015:C:G | acceptor_gain | 0.5200 |
| 11:6200022:C:G | acceptor_gain | 0.5200 |
| 11:6199849:T:A | acceptor_gain | 0.5100 |
| 11:6200021:ACACC:A | acceptor_gain | 0.5100 |
| 11:6200042:T:A | acceptor_gain | 0.5100 |
AlphaMissense
2022 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:6199989:T:C | F256L | 0.949 |
| 11:6199991:C:A | F256L | 0.949 |
| 11:6199991:C:G | F256L | 0.949 |
| 11:6200028:T:C | F269L | 0.947 |
| 11:6200030:T:A | F269L | 0.947 |
| 11:6200030:T:G | F269L | 0.947 |
| 11:6199743:T:C | F174L | 0.939 |
| 11:6199745:C:A | F174L | 0.939 |
| 11:6199745:C:G | F174L | 0.939 |
| 11:6199416:T:C | F65L | 0.935 |
| 11:6199418:T:A | F65L | 0.935 |
| 11:6199418:T:G | F65L | 0.935 |
| 11:6199542:T:C | F107L | 0.923 |
| 11:6199544:C:A | F107L | 0.923 |
| 11:6199544:C:G | F107L | 0.923 |
| 11:6199996:T:A | I258K | 0.909 |
| 11:6199996:T:G | I258R | 0.872 |
| 11:6199734:T:C | F171L | 0.857 |
| 11:6199736:T:A | F171L | 0.857 |
| 11:6199736:T:G | F171L | 0.857 |
| 11:6200007:T:C | F262L | 0.848 |
| 11:6200009:C:A | F262L | 0.848 |
| 11:6200009:C:G | F262L | 0.848 |
| 11:6199946:G:C | K241N | 0.836 |
| 11:6199946:G:T | K241N | 0.836 |
| 11:6199592:G:A | M123I | 0.823 |
| 11:6199592:G:C | M123I | 0.823 |
| 11:6199592:G:T | M123I | 0.823 |
| 11:6200029:T:G | F269C | 0.823 |
| 11:6200098:C:A | A292D | 0.821 |
dbSNP variants (sampled 300 via entrez): RS1001617260 (11:6197287 T>A), RS1002620091 (11:6198790 T>C), RS1002630039 (11:6198460 C>T), RS1003628764 (11:6200176 G>T), RS1005588239 (11:6200488 T>C), RS1006056488 (11:6200247 G>A), RS1006414270 (11:6198808 C>A), RS1006723926 (11:6198419 A>G), RS1006875122 (11:6199701 ATTG>A), RS1007233607 (11:6199977 G>A,T), RS1008495409 (11:6198435 C>T), RS1008964072 (11:6198206 T>C), RS1009784078 (11:6200582 C>T), RS1012346339 (11:6200535 T>C), RS1015444635 (11:6197434 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Plant Extracts | decreases expression, affects cotreatment | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Sodium Selenite | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.